177 related articles for article (PubMed ID: 37215211)
1. Differential effects of high dose omega-3 fatty acids on metabolism and inflammation in patients with obesity: eicosapentaenoic and docosahexaenoic acid supplementation.
Borja-Magno A; Guevara-Cruz M; Flores-López A; Carrillo-Domínguez S; Granados J; Arias C; Perry M; Sears B; Bourges H; Gómez FE
Front Nutr; 2023; 10():1156995. PubMed ID: 37215211
[TBL] [Abstract][Full Text] [Related]
2. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
3. Supplementation with EPA and DHA omega-3 fatty acids improves peripheral immune cell mitochondrial dysfunction and inflammation in subjects with obesity.
Borja-Magno AI; Furuzawa-Carballeda J; Guevara-Cruz M; Arias C; Granados J; Bourges H; Tovar AR; Sears B; Noriega LG; Gómez FE
J Nutr Biochem; 2023 Oct; 120():109415. PubMed ID: 37437746
[TBL] [Abstract][Full Text] [Related]
4. Fish oil supplementation alters circulating eicosanoid concentrations in young healthy men.
Zulyniak MA; Perreault M; Gerling C; Spriet LL; Mutch DM
Metabolism; 2013 Aug; 62(8):1107-13. PubMed ID: 23522836
[TBL] [Abstract][Full Text] [Related]
5. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
[TBL] [Abstract][Full Text] [Related]
6. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
7. A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
Allaire J; Couture P; Leclerc M; Charest A; Marin J; Lépine MC; Talbot D; Tchernof A; Lamarche B
Am J Clin Nutr; 2016 Aug; 104(2):280-7. PubMed ID: 27281302
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of EPA, DPA and DHA on cardio-metabolic risk factors in high-fat diet fed mice.
Guo XF; Sinclair AJ; Kaur G; Li D
Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():47-55. PubMed ID: 29113747
[TBL] [Abstract][Full Text] [Related]
9. Ethyl EPA and ethyl DHA cause similar and differential changes in plasma lipid concentrations and lipid metabolism in subjects with low-grade chronic inflammation.
So J; Asztalos BF; Horvath K; Lamon-Fava S
J Clin Lipidol; 2022; 16(6):887-894. PubMed ID: 36522805
[TBL] [Abstract][Full Text] [Related]
10. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
11. EPA+DHA, but not ALA, Improved Lipids and Inflammation Status in Hypercholesterolemic Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
Zhou Q; Zhang Z; Wang P; Zhang B; Chen C; Zhang C; Su Y
Mol Nutr Food Res; 2019 May; 63(10):e1801157. PubMed ID: 30900815
[TBL] [Abstract][Full Text] [Related]
12. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
[TBL] [Abstract][Full Text] [Related]
13. Effects of supplemental long-chain omega-3 fatty acids and erythrocyte membrane fatty acid content on circulating inflammatory markers in a randomized controlled trial of healthy adults.
Flock MR; Skulas-Ray AC; Harris WS; Gaugler TL; Fleming JA; Kris-Etherton PM
Prostaglandins Leukot Essent Fatty Acids; 2014 Oct; 91(4):161-8. PubMed ID: 25091379
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial.
de la Torre-Aguilar MJ; Gomez-Fernandez A; Flores-Rojas K; Martin-Borreguero P; Mesa MD; Perez-Navero JL; Olivares M; Gil A; Gil-Campos M
Front Nutr; 2022; 9():790250. PubMed ID: 35425788
[TBL] [Abstract][Full Text] [Related]
15. Red Blood Cell Docosapentaenoic Acid (DPA n-3) is Inversely Associated with Triglycerides and C-reactive Protein (CRP) in Healthy Adults and Dose-Dependently Increases Following n-3 Fatty Acid Supplementation.
Skulas-Ray AC; Flock MR; Richter CK; Harris WS; West SG; Kris-Etherton PM
Nutrients; 2015 Aug; 7(8):6390-404. PubMed ID: 26247967
[TBL] [Abstract][Full Text] [Related]
16. Effects of docosahexaenoic acid-rich n-3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study.
Vedin I; Cederholm T; Freund Levi Y; Basun H; Garlind A; Faxén Irving G; Jönhagen ME; Vessby B; Wahlund LO; Palmblad J
Am J Clin Nutr; 2008 Jun; 87(6):1616-22. PubMed ID: 18541548
[TBL] [Abstract][Full Text] [Related]
17. Reducing the dietary omega-6:omega-3 utilizing α-linolenic acid; not a sufficient therapy for attenuating high-fat-diet-induced obesity development nor related detrimental metabolic and adipose tissue inflammatory outcomes.
Enos RT; Velázquez KT; McClellan JL; Cranford TL; Walla MD; Murphy EA
PLoS One; 2014; 9(4):e94897. PubMed ID: 24733548
[TBL] [Abstract][Full Text] [Related]
18. Supplementation with high-dose docosahexaenoic acid increases the Omega-3 Index more than high-dose eicosapentaenoic acid.
Allaire J; Harris WS; Vors C; Charest A; Marin J; Jackson KH; Tchernof A; Couture P; Lamarche B
Prostaglandins Leukot Essent Fatty Acids; 2017 May; 120():8-14. PubMed ID: 28515020
[TBL] [Abstract][Full Text] [Related]
19. The impact of an omega-3 fatty acid rich lipid emulsion on fatty acid profiles in critically ill septic patients.
Hall TC; Bilku DK; Neal CP; Cooke J; Fisk HL; Calder PC; Dennison AR
Prostaglandins Leukot Essent Fatty Acids; 2016 Sep; 112():1-11. PubMed ID: 27637335
[TBL] [Abstract][Full Text] [Related]
20. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
